Pharma and Biotech (DLS30)

 0.00
   
  • 52 Week High: NULL
  • 52 Week Low: 0.00

Latest ShareCast News

Ixico reports higher interim revenue, larger order book

By Josh White

Date: Tuesday 19 May 2026

(Sharecast News) - Ixico reported higher interim revenue and a larger order book on Tuesday, as new contract wins, extensions and increased biomarker analysis activity supported growth in the first half.

Avacta strengthens oncology position in 2025

By Josh White

Date: Tuesday 19 May 2026

(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, with progress across its 'preCISION' tumour-activated drug delivery platform and cash runway extended into the first quarter of 2027.

Citi sees buying opportunity at AstraZeneca after recent falls

By Benjamin Chiou

Date: Monday 18 May 2026

(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 0.00
Closing Price Change 0.00
% Change 0.00 %
--26 Close 0.00

Top Risers

Price Change
IXI 8.63p +27.8%
COIL 10.00p +14.3%
SVNS 0.25p +9.9%
SCLP 26.50p +5.7%
TLM 8.00p +5.3%
IMM 4.52p +5.1%
AGY 9.76p +4.1%
CHLL 0.40p +3.7%
VRCI 0.43p +3.0%
FUM 0.70p +2.9%

Top Fallers

Price Change
THAT 0.68p -5.3%
RENX 1.80p -3.6%
AVCT 82.00p -3.1%
VAL 0.19p -2.6%
OXB 594.00p -2.5%
HCM 178.25p -2.1%
PRTC 129.80p -1.8%
FARN 42.00p -1.8%
ONT 118.00p -1.7%
SAR 21.00p -1.4%

Top of Page